{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:35:02Z","timestamp":1764732902382},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s10038-020-00859-w","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T17:03:10Z","timestamp":1603386190000},"page":"315-320","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of rearrangements of the CFTR gene in patients from Turkey with CFTR-related disorders: frequent exon 2 deletion"],"prefix":"10.1038","volume":"66","author":[{"given":"Mehmet Bugrahan","family":"Duz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelin","family":"Ozyavuz Cubuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"859_CR1","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","volume":"10","author":"C Bombieri","year":"2011","unstructured":"Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros. 2011;10:S86\u2013102.","journal-title":"J Cyst Fibros."},{"key":"859_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0022-3476(98)70441-X","volume":"132","author":"A Hamosh","year":"1998","unstructured":"Hamosh A, FitzSimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr. 1998;132:255\u20139.","journal-title":"J Pediatr."},{"key":"859_CR3","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/jama.281.23.2217","volume":"281","author":"V Mak","year":"1999","unstructured":"Mak V, Zielenski J, Tsui LC, Durie P, Zini A, Martin S, et al. Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia. JAMA. 1999;281:2217\u201324.","journal-title":"JAMA."},{"key":"859_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/humu.9281","volume":"24","author":"OM Alper","year":"2004","unstructured":"Alper OM, Wong LJ, Young S, Pearl M, Graham S, Sherwin J, et al. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Hum Mutat. 2004;24:353.","journal-title":"Hum Mutat."},{"key":"859_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/GIM.0b013e31818e55a2","volume":"10","author":"SM Moskowitz","year":"2008","unstructured":"Moskowitz SM, Chmiel JF, Sternen DL, Cheng E, Gibson RL, Marshall SG, et al. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med. 2008;10:851\u201368.","journal-title":"Genet Med."},{"key":"859_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/03009748709165272","volume":"16","author":"RH Derksen","year":"1987","unstructured":"Derksen RH, Bouma BN, Kater L. The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus. Scand J Rheumatol. 1987;16:185\u201392.","journal-title":"Scand J Rheumatol."},{"key":"859_CR7","unstructured":"Ong T, Marshall SG, Karczeski BA, et al. Cystic Fibrosis and Congenital Absence of the Vas Deferens. 2001 Mar 26 [Updated 2017 Feb 2]. GeneReviews\u00ae [Internet]."},{"key":"859_CR8","doi-asserted-by":"publisher","first-page":"W163","DOI":"10.1093\/nar\/gkn198","volume":"36","author":"R Owczarzy","year":"2008","unstructured":"Owczarzy R, Tataurov AV, Wu Y, Manthey JA, McQuisten KA, Almabrazi HG, et al. IDT SciTools: a suite for analysis and design of nucleic acid oligomers. Nucleic Acids Res. 2008;36:W163\u20139.","journal-title":"Nucleic Acids Res"},{"key":"859_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods."},{"key":"859_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s004390000246","volume":"106","author":"T D\u00f6rk","year":"2000","unstructured":"D\u00f6rk T, Macek M, Mekus F, T\u00fcmmler B, Tzountzouris J, Casals T, et al. Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet. 2000;106:259\u201368.","journal-title":"Hum Genet"},{"key":"859_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ajmg.10721","volume":"113","author":"MO Kilin\u00e7","year":"2002","unstructured":"Kilin\u00e7 MO, Ninis VN, Da\u011fli E, Demirkol M, Ozkinay F, Arikan Z, et al. Highest heterogeneity for cystic fibrosis: 36 mutations account for 75% of all CF chromosomes in Turkish patients. Am J Med Genet. 2002;113:250\u20137.","journal-title":"Am J Med Genet."},{"key":"859_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/gte.2007.0046","volume":"12","author":"P Lakeman","year":"2008","unstructured":"Lakeman P, Gille JJ, Dankert-Roelse JE, Heijerman HG, Munck A, Iron A, et al. CFTR mutations in Turkish and North African cystic fibrosis patients in Europe: implications for screening. Genet Test. 2008;12:25\u201335.","journal-title":"Genet Test."},{"key":"859_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s004390050683","volume":"102","author":"T Onay","year":"1998","unstructured":"Onay T, Topaloglu O, Zielenski J, Gokgoz N, Kayserili H, Camcioglu Y, et al. Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I). Hum Genet. 1998;102:224\u201330.","journal-title":"Hum Genet."},{"key":"859_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.ejhg.5201590","volume":"14","author":"C F\u00e9rec","year":"2006","unstructured":"F\u00e9rec C, Casals T, Chuzhanova N, Macek M, Bienvenu T, Holubova A, et al. Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur J Hum Genet. 2006;14:567\u201376.","journal-title":"Eur J Hum Genet."},{"key":"859_CR15","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1136\/jmg.2004.022400","volume":"41","author":"F Niel","year":"2004","unstructured":"Niel F, Martin J, Dastot-Le Moal F, Costes B, Boissier B, Delattre V, et al. Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis. J Med Genet. 2004;41:e118.","journal-title":"J Med Genet."},{"key":"859_CR16","unstructured":"http:\/\/www.genet.sickkids.on.ca\/ 2020."},{"key":"859_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-019-0815-x","volume":"20","author":"NLR Indika","year":"2019","unstructured":"Indika NLR, Vidanapathirana DM, Dilanthi HW, Kularatnam GAM, Chandrasiri NDPD, Jasinge E. Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka. BMC Med Genet. 2019;20:89.","journal-title":"BMC Med Genet."},{"key":"859_CR18","first-page":"613863","volume":"2014","author":"V Neocleous","year":"2014","unstructured":"Neocleous V, Yiallouros PK, Tanteles GA, Costi C, Moutafi M, Ioannou P, et al. Apparent homozygosity of p.Phe508del in CFTR due to a large gene deletion of exons 4-11. Case Rep Genet. 2014;2014:613863.","journal-title":"Case Rep Genet."},{"key":"859_CR19","doi-asserted-by":"crossref","unstructured":"Chevalier-Porst F, Bonardot AM, Chazalette JP, Mathieu M, Bozon D. 40 kilobase deletion (CF 40 kb del 4-10) removes exons 4 to 10 of the cystic fibrosis transmembrane conductance regulator gene. Hum Mutat. 1998;S291-4.","DOI":"10.1002\/humu.1380110191"},{"key":"859_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jcf.2007.06.001","volume":"7","author":"R Alibakhshi","year":"2008","unstructured":"Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J Cyst Fibros. 2008;7:102\u20139.","journal-title":"J Cyst Fibros."},{"key":"859_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/humu.20009","volume":"23","author":"MP Audr\u00e9zet","year":"2004","unstructured":"Audr\u00e9zet MP, Chen JM, Ragu\u00e9n\u00e8s O, Chuzhanova N, Giteau K, Le Mar\u00e9chal C, et al. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat. 2004;23:343\u201357.","journal-title":"Hum Mutat."},{"key":"859_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ppul.24299","volume":"54","author":"E Atag","year":"2019","unstructured":"Atag E, Bas Ikizoglu N, Ergenekon AP, Gokdemir Y, Eralp EE, Ata P, et al. Novel mutations and deletions in cystic fibrosis in a tertiary cystic fibrosis center in Istanbul. Pediatr Pulmonol. 2019;54:743\u201350.","journal-title":"Pediatr Pulmonol."},{"key":"859_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12576-018-0626-4","volume":"69","author":"K Wakabayashi-Nakao","year":"2019","unstructured":"Wakabayashi-Nakao K, Yu Y, Nakakuki M, Hwang TC, Ishiguro H, Sohma Y. Characterization of \u0394(G970-T1122)-CFTR, the most frequent CFTR mutant identified in Japanese cystic fibrosis patients. J Physiol Sci. 2019;69:103\u201312.","journal-title":"J Physiol Sci."},{"key":"859_CR24","doi-asserted-by":"publisher","first-page":"103681","DOI":"10.1016\/j.ejmg.2019.103681","volume":"62","author":"YB Sohn","year":"2019","unstructured":"Sohn YB, Ko JM, Jang JY, Seong MW, Park SS, Suh DI, et al. Deletion of exons 16-17b of CFTR is frequently identified in Korean patients with cystic fibrosis. Eur J Med Genet. 2019;62:103681.","journal-title":"Eur J Med Genet."},{"key":"859_CR25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/(SICI)1098-1004(1999)13:4<337::AID-HUMU13>3.0.CO;2-C","volume":"13","author":"I Lerer","year":"1999","unstructured":"Lerer I, Laufer-Cahana A, Rivlin JR, Augarten A, Abeliovich D. A large deletion mutation in the CFTR gene (3120+1Kbdel8.6Kb): a founder mutation in the Palestinian Arabs. Mutation in brief no. 231. Online. Hum Mutat. 1999;13:337.","journal-title":"Hum Mutat."},{"key":"859_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2353\/jmoldx.2006.050146","volume":"8","author":"V Fa\u00e0","year":"2006","unstructured":"Fa\u00e0 V, Bettoli PP, Demurtas M, Zanda M, Ferri V, Cao A, et al. A new insertion\/deletion of the cystic fibrosis transmembrane conductance regulator gene accounts for 3.4% of cystic fibrosis mutations in Sardinia: implications for population screening. J Mol Diagn. 2006;8:499\u2013503.","journal-title":"J Mol Diagn."},{"key":"859_CR27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1017\/S0021932016000055","volume":"48","author":"S Kaplan","year":"2016","unstructured":"Kaplan S, Pinar G, Kaplan B, Aslantekin F, Karabulut E, Ayar B, et al. The prevalence of consanguineous marriages and affecting factors in Turkey: a national survey. J Biosoc Sci. 2016;48:616\u201330.","journal-title":"J Biosoc Sci."},{"key":"859_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/humu.23276","volume":"38","author":"M Claustres","year":"2017","unstructured":"Claustres M, Th\u00e8ze C. des Georges M, Baux D, Girodon E, Bienvenu T, et al. CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants. Hum Mutat. 2017;38:1297\u2013315.","journal-title":"Hum Mutat"},{"key":"859_CR29","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41588-018-0215-8","volume":"50","author":"CWK Chiang","year":"2018","unstructured":"Chiang CWK, Marcus JH, Sidore C, Biddanda A, Al-Asadi H, Zoledziewska M, et al. Genomic history of the Sardinian population. Nat Genet. 2018;50:1426\u201334.","journal-title":"Nat Genet"},{"key":"859_CR30","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"JS Elborn","year":"2016","unstructured":"Elborn JS. Cystic fibrosis. Lancet. 2016;388:2519\u201331.","journal-title":"Lancet."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-00859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-00859-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-00859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T23:04:41Z","timestamp":1634857481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-00859-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1038\/s10038-020-00859-w","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was conducted in accordance with the Declaration of Helsinki (1964) and was approved by ethics committee of Haseki Training and Research Hospital (ID:2020-76). Consent forms were obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}